Tailored treatment for acute myeloid leukaemia
11 December 2018 | By European Pharmaceutical Review
The screening of leukaemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for AML...
List view / Grid view
Clinical Trials
Ocrelizumab reccommended for relapsing remitting multiple sclerosis
10 December 2018 | By European Pharmaceutical Review
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
FDA grants frontotemporal dementia drug Orphan-Drug Designation
10 December 2018 | By European Pharmaceutical Review
A dementia drug has been given Orphan Drug Designation by the FDA, meaning this special status will qualify sponsors of the drug for development incentives.
Oxybutynin improves quality of life for breast cancer survivors
7 December 2018 | By European Pharmaceutical Review
Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life...
PET tracer able to image tau in Alzheimer’s disease patients
6 December 2018 | By European Pharmaceutical Review
Research into detecting tau proteins in the brains of Alzheimer's patients has shown that a specific tracer could detect and measure the protein levels...
Phase III KATHERINE trial crossed early reporting boundary and met its primary endpoint
5 December 2018 | By European Pharmaceutical Review
A phase III clinical trial showed that neoadjuvant chemotherapy and trastuzumab reduced the risk of recurrence of HER2-positive early-stage breast cancer...
Trastuzumab taken with carvedilol leads to less heart damage
5 December 2018 | By Iqra Farooq (European Pharmaceutical Review)
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
Rivaroxaban reduced blood clots and related death in cancer patients
4 December 2018 | By European Pharmaceutical Review
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
Global 2-year trial reports on CAR-T therapy to treat DLBCL
3 December 2018 | By European Pharmaceutical Review
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
New brain circuits formed for motor function after Parkinson’s therapy
29 November 2018 | By European Pharmaceutical Review
A gene therapy called AAV2-GAD has been associated with improved motor function, leading to researchers looking at its use in an upcoming Phase III trial...
Lanadelumab effective in reducing hereditary angioedema attacks
29 November 2018 | By European Pharmaceutical Review
Results of a clinical trial has led to the FDA approval of a monoclonal antibody drug called lanadelumab, to treat hereditary angioedema attacks...
Pulsed radiofrequency could relieve sciatica and back pain
28 November 2018 | By European Pharmaceutical Review
The use of pRF also could improve outcomes for patients set to receive corticosteroid injections, and was found to be minimally invasive with good results...
Canada clinical trial on personalised medicine for prostate cancer
28 November 2018 | By European Pharmaceutical Review
A clinical trial could be the world's first to look at personalised medicine in prostate cancer, with patients taking a therapy based on their DNA markers...
Whitepaper: Ten things you should know before contracting a custom synthesis project
26 November 2018 | By Eurofins
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
Meta-surface used to correct for chromatic aberrations across lenses
22 November 2018 | By European Pharmaceutical Review
Harvard researchers have developed a metacorrector, a single-layer surface of nanostructures that can eliminate chromatic aberrations across visible light...
Follow: